Emory University a Research News
  a March 31, 2010 a
a a
Paul Wolpe, PhDPaul Wolpe, PhD  

Sound Science: Marrying Ethics and Medicine
Listen to Sound Science as bioethicist Paul Wolpe discusses some of the many provocative ethical issues in medicine that require thoughtful consideration and complex decision making by researchers and physicians.
Read and listen...

a a

The Fragile X team with a study participant
The Fragile X team with
a study participant

Decades of Fragile X Research Lead to Testing of Targeted Treatment
Emory scientists have been research leaders in fragile X syndrome—the most common inherited cause of intellectual disability. Geneticist Steve Warren headed the 1991 team that identified the mutated gene on the X chromosome, and he has continued making new discoveries. Now a possible treatment is in sight, and Emory is part of a clinical trial testing targeted drug therapy. Read more...
a a
Chymase Inhibitors
Chymase-producing cells in the human heart (shown in pink)
Chymase Inhibitors Could Boost Treatment for Damaged Hearts
Millions of patients with high blood pressure and heart failure take ACE inhibitors to prevent the body from processing angiotensin II, a hormone that constricts blood vessels. Now scientists think blocking another heart enzyme called chymase may enhance the effects of ACE inhibitors after heart attack. Read more...
a a
Are Obesity and Metabolic Disease Contagious?
Are Obesity and Metabolic Disease Contagious?
It's often assumed the obesity epidemic is driven by high-calorie foods, a sedentary lifestyle, and undisciplined eating; however, intestinal bacteria also may contribute to changes in appetite and metabolism. Populations of intestinal bacteria differ between obese and lean humans, and in the lab, these bacteria can transfer increased appetite and insulin resistance from mouse to mouse. Read more...
a a
Gang Bao, PhD Gang Bao, PhD
New National Science Foundation Center Advances Cell Systems Research
Georgia Tech and Emory biomedical engineers will partner with MIT and the University of Illinois through a $25 million NSF grant for the Emergent Behaviors of Integrated Cellular Systems Center. EBICS will focus on complex biological systems, create new educational programs, and involve under-represented groups in science and engineering. Read more...

Woodruff Health Sciences Center
Link to the Current Issue More Research NewsArchives Contact Us Holly Korshun David Stephens Jeffrey Molter